A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults

Christine A. Shaw; Allison August; Stephan Bart; Peta-Gay Jackson Booth; Conor Knightly; Trevor Brasel; Scott C. Weaver; HongHong Zhou; Lori Panther

doi:10.1016/j.vaccine.2023.04.064

A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults

著者: Christine A. Shaw, Allison August, Stephan Bart, Peta-Gay Jackson Booth, Conor Knightly, Trevor Brasel, Scott C. Weaver, HongHong Zhou, Lori Panther - Vaccine 2023 被引用: 40

A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults | Litlas